CEL-SCI Corporation (CVM)

USD 0.62

(-18.09%)

Revenue Summary of CEL-SCI Corporation

  • CEL-SCI Corporation's latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • CEL-SCI Corporation's latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • CEL-SCI Corporation reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • CEL-SCI Corporation reported a annual revenue of - USD in annual revenue 2021, down -100.0% from previous year.
  • CEL-SCI Corporation reported a quarterly revenue of - USD for 2024 Q3, down 0.0% from previous quarter.
  • CEL-SCI Corporation reported a quarterly revenue of - USD for 2024 Q1, down 0.0% from previous quarter.

Annual Revenue Chart of CEL-SCI Corporation (2023 - 1989)

Historical Annual Revenue of CEL-SCI Corporation (2023 - 1989)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD -100.0%
2020 558.66 Thousand USD 20.73%
2019 462.75 Thousand USD -2.9%
2018 476.55 Thousand USD 590.46%
2017 69.02 Thousand USD -75.79%
2016 285.05 Thousand USD -56.64%
2015 657.37 Thousand USD 248875.32%
2014 264.03 USD 65.45%
2013 159.58 USD -99.94%
2012 254.61 Thousand USD -73.37%
2011 956.15 Thousand USD 523.71%
2010 153.3 Thousand USD 91.4%
2009 80.09 Thousand USD 1481.3%
2008 5065.00 USD -91.12%
2007 57.04 Thousand USD -54.53%
2006 125.45 Thousand USD -53.52%
2005 269.92 Thousand USD -17.07%
2004 325.47 Thousand USD 2.25%
2003 318.3 Thousand USD -17.31%
2002 384.93 Thousand USD 2.32%
2001 376.22 Thousand USD -6.42%
2000 402.01 Thousand USD 0.5%
1999 400 Thousand USD 300.0%
1998 100 Thousand USD -75.0%
1997 400 Thousand USD 33.33%
1996 300 Thousand USD 200.0%
1995 100 Thousand USD 0.0%
1994 100 Thousand USD -90.0%
1993 1 Million USD 150.0%
1992 400 Thousand USD 300.0%
1991 100 Thousand USD 0.0%
1990 100 Thousand USD 0.0%
1989 100 Thousand USD 0.0%

Peer Revenue Comparison of CEL-SCI Corporation

Name Revenue Revenue Difference
AIM ImmunoTech Inc. 202 Thousand USD 100.0%
Ampio Pharmaceuticals, Inc. - USD NaN%
Armata Pharmaceuticals, Inc. 4.52 Million USD 100.0%
Actinium Pharmaceuticals, Inc. 81 Thousand USD 100.0%
Azitra, Inc. 686 Thousand USD 100.0%
Can-Fite BioPharma Ltd. 743 Thousand USD 100.0%
Chromocell Therapeutics Corporation - USD NaN%
Calidi Biotherapeutics, Inc. - USD NaN%
iBio, Inc. 225 Thousand USD 100.0%
Lineage Cell Therapeutics, Inc. 8.94 Million USD 100.0%
MAIA Biotechnology, Inc. - USD NaN%
Matinas BioPharma Holdings, Inc. 1.09 Million USD 100.0%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD 100.0%
NovaBay Pharmaceuticals, Inc. 14.72 Million USD 100.0%
NanoViricides, Inc. - USD NaN%
Oragenics, Inc. 37.65 Thousand USD 100.0%
BiomX Inc. -357 Thousand USD 100.0%
BiomX Inc. -357 Thousand USD 100.0%
Protalix BioTherapeutics, Inc. 65.49 Million USD 100.0%
Palatin Technologies, Inc. 4.49 Million USD 100.0%
Scorpius Holdings, Inc. 6.99 Million USD 100.0%